HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis.

Abstract
We did a meta-analysis of all published polychemotherapy vs supportive care clinical trials in patients with non-resectable non small cell lung cancer. 7 studies with more than 700 patients were selected. We used the number of deaths at 3, 6, 9, 12, and 18 months as the endpoints because we were unable to obtain all the individual data. Our analysis showed a reduction in mortality during the first 6 months with polychemotherapy. Although small, this increase in survival, together with an improved quality of life, suggests that polychemotherapy should be recommended for patients with non-resectable non small cell lung cancer.
AuthorsP J Souquet, F Chauvin, J P Boissel, R Cellerino, Y Cormier, P A Ganz, S Kaasa, J L Pater, E Quoix, E Rapp
JournalLancet (London, England) (Lancet) Vol. 342 Issue 8862 Pg. 19-21 (Jul 03 1993) ISSN: 0140-6736 [Print] England
PMID8100290 (Publication Type: Journal Article, Meta-Analysis)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, mortality)
  • Humans
  • Lung Neoplasms (drug therapy, mortality)
  • Quality of Life
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: